These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 14635365

  • 1. Infusion therapy in severe heart failure. A reappraisal.
    Campana C, Scelsi L, Serio A.
    Ital Heart J; 2003 May; 4 Suppl 2():15S-21S. PubMed ID: 14635365
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The development of new medical treatments for acute decompensated heart failure.
    Teerlink JR.
    Heart Fail Monit; 2002 May; 2(4):129-37. PubMed ID: 12634887
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S, Warfield KT, Wood CM, Miller WL.
    Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG, Nikitin N, McGowan J.
    Expert Rev Cardiovasc Ther; 2004 Jan 15; 2(1):9-19. PubMed ID: 15038409
    [Abstract] [Full Text] [Related]

  • 10. New therapies in acute decompensated heart failure.
    Gauthier N, Anselm AH, Haddad H.
    Curr Opin Cardiol; 2008 Mar 15; 23(2):134-40. PubMed ID: 18303526
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure.
    Elkayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade M, Warnica JW, Young JB, Rayburn BK, Rogers JG, DeMarco T, Leier CV.
    Am Heart J; 2007 Jan 15; 153(1):98-104. PubMed ID: 17174645
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute decompensated heart failure: best evidence and current practice.
    Mehta R, Feldman D.
    Minerva Cardioangiol; 2005 Dec 15; 53(6):537-47. PubMed ID: 16333237
    [Abstract] [Full Text] [Related]

  • 18. [Rationale and clinical evidence for the effects of new pharmacological treatments for heart failure].
    Tamargo J, López-Sendón J.
    Rev Esp Cardiol; 2004 May 15; 57(5):447-64. PubMed ID: 15151778
    [Abstract] [Full Text] [Related]

  • 19. [What is new in the medical management of acute heart failure?].
    Meyer P, White M, Keller RF, Lerch R, Hullin R.
    Rev Med Suisse; 2010 Jun 09; 6(252):1211-7. PubMed ID: 20614757
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.